The TECNIS SynergyTM Toric II OptiBlue® PC-IOL for astigmatic patients is now available in India, according to Johnson & Johnson Vision, a world authority on eye health and a division of the Johnson & Johnson Medical Devices Companies. The continuous-range-of-vision TECNIS Synergy™ Toric II IOL is designed for rotational stability, locking in visual performance and delivering the high-quality vision.
Over 100 million eyes are affected by cataracts, the most common cause of avoidable blindness, and more than 90% of people have cataracts by the time they are 65. The majority of people will experience cataracts at some point in their lives, and current cataract surgery has a success record of nearly 98%.
Nearly 73% of Indian individuals aged 60 and over have cataracts, which, if ignored, will eventually worsen vision. Reduced vision quality, depth perception, and distance and near visual acuity are all effects of astigmatism. All cataracts will eventually require surgical removal and replacement with an IOL or artificial lens (Intraocular lens).
Surgical Vision India’s Burzin Shahana, Country Manager for Johnson & Johnson Vision, stated: “We at Johnson & Johnson Vision are actively working with Indian medical experts to minimize the prevalence of cataracts using cutting-edge, high-quality products and technologies. For cataract patients with astigmatism, TECNIS Synergy™ Toric II OptiBlue® PC-IOL is an advanced IOL option that provides patients with improved independence from glasses and clearer vision.”
At the time of cataract surgery, the new TECNIS Synergy™ Toric II OptiBlue® PC-IOL (Intraocular Lens) offers the chance to address both presbyopia and astigmatism. It’s intended to:
To promote sight independence, offer excellent, continuous vision across the entire range of distances, including far, intermediate, and near. These toric IOLs correct corneal astigmatism and spherical aberration.
A unique diffractive surface on the posterior optic of the lens is created to correct chromatic aberration for improved contrast sensitivity and offer high-quality vision over a wide range of distances. This lens’s diffractive construction produces strong visual acuities at all distances and a continuous field of view from far to close up, increasing the degree to which one can function without glasses.
The intraocular lens is locked in place by a new frosted haptic design that improves the friction between the lens’ haptic surface and the capsular bag for rotational stability and visual performance.
The Central Drugs Standard Control Organization in India has authorized TECNIS Synergy™ Toric II OptiBlue® PC-IOL (CDSCO).
About Johnson & Johnson Vision
We at Johnson & Johnson Vision, a division of the Johnson & Johnson Medical Devices Companies, have an audacious goal: to alter the course of global eye health. With products and solutions that address unmet needs like refractive error, cataracts, and dry eye, we bring innovation that enables eye care professionals to improve outcomes for patients throughout their lifetimes through our operating companies.
About Johnson & Johnson Medical Devices Companies
We at Johnson & Johnson Medical Devices Companies are committed to assisting individuals in leading fulfilling lives. We address urgent healthcare issues and take courageous actions that result in new standards of care while enhancing patient experiences, building on more than a century of experience. We are paving the road for a healthy future for everyone, everywhere, through surgery, orthopaedics, vision, and interventional solutions.
The companies Johnson & Johnson Surgical Vision, Inc., Johnson & Johnson Vision Care, Inc., and their affiliates are represented by Johnson & Johnson Vision.
Within Johnson & Johnson’s Medical Devices segment, the Johnson & Johnson Medical Devices Companies include the businesses of surgery, orthopaedics, vision, and interventional solutions.
